MultiplexDX
PrivateLast Round
Grant
Mar 7, 2025
Total Funding Raised
$4.82M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MultiplexDX operates in Healthcare & Life Sciences and is based in Bratislava. Its latest recorded funding round was a VC Round in June 2023.
MultiplexDX is a biotechnology company that manufactures diagnostics kits and provides services intended to eliminate cancer misdiagnosis. The company's services combine molecular biology and histopathological methods for the treatment of tumors and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MultiplexDX Comparables
Compare MultiplexDX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Veracyte | 78% | |
| Agendia | 76% | |
| Rna Diagnostics Inc. | 76% |
For institutional investors. Book with your work email.
MultiplexDX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 7, 2025 | ||||
| VC Round | Jun 27, 2023 | ||||
| Grant | Dec 12, 2019 | ||||
| Seed | Sep 1, 2018 | ||||
| Grant | Jul 1, 2018 | ||||
Seed | May 16, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MultiplexDX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Neulogy Ventures | VC Round, Seed |
| European Innovation Council Fund | Grant |
| Slovak Investment Holding | VC Round |
| Crowdberry | VC Round, Seed |
| Lumus Investment Collective | VC Round |
| Ministry of Education, Research, Development and Youth of the Slovak Republic | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 12, representing 27% of headcount.
- Aug 24, 2025
Grew 15% QoQ, from 39 to 45 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardOct 29, 2026
Pavol Čekan, founder and CEO of MultiplexDX International, receives the Public Award with 16,433 of 26,259 valid votes.
For institutional investors. Book with your work email.
MultiplexDX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MultiplexDX's valuation, stock price, and market status.
Is MultiplexDX a public or private company?
MultiplexDX is a private company.
What is the current stock price of MultiplexDX?
MultiplexDX is a private company, so its shares have no public market price. Caplight tracks MultiplexDX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MultiplexDX worth (valuation)?
Valuation information for MultiplexDX is not publicly available.
Can I buy MultiplexDX stock?
MultiplexDX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MultiplexDX's last funding round?
MultiplexDX's most recent funding round was Grant on March 7, 2025.
Who are the main investors in MultiplexDX?
Key investors in MultiplexDX include Neulogy Ventures.
Will MultiplexDX IPO soon?
No public IPO plans have been announced for MultiplexDX.
How can I track MultiplexDX secondary market activity?
Caplight tracks bids, offers, and trades in MultiplexDX's shares on secondary markets.